ShervinAssassiMD
Rheumatology • Houston, TXProfessor & Director, Division of Rheumatology, University of Texas Health Science Center at Houston
Dr. Assassi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431 Fannin St
Msb 5.270
Houston, TX 77030Phone+1 713-500-6900Fax+1 713-500-0580
Education & Training
University of Texas Health Science Center at HoustonFellowship, Rheumatology, 2003 - 2005- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2000 - 2003
Albert Ludwigs University Faculty of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2005 - 2025
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 36 citationsGenetics of scleroderma: implications for personalized medicine?Shervin Assassi, Timothy R D J Radstake, Maureen D. Mayes, Javier Martín
BMC Medicine. 2013-01-11 - 46 citationsAssociation of Interleukin 23 Receptor Polymorphisms with Anti-Topoisomerase-I Positivity and Pulmonary Hypertension in Systemic SclerosisSandeep K. Agarwal, Pravitt Gourh, Sanjay Shete, Gene Paz, Dipal Divecha
The Journal of Rheumatology. 2009-12-01 - 297 citationsGenome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusTimothy R D J Radstake, Olga Y. Gorlova, Blanca Rueda, Jose Ezequiel Martin, Behrooz Z. Alizadeh
Nature Genetics. 2010-05-01
Journal Articles
- The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma CohortsDaniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
Press Mentions
Durable Efficacy for Drug Preventing Lung Progression in Systemic SclerosisJuly 20th, 2022- Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus YearsNovember 8th, 2020
Dr. Shervin Assassi: New Chair of the ACR Committee on Journal PublicationsApril 18th, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
